These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 22111871

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy.
    Wen L, Zhao Z, Wang Z, Xiao J, Birn H, Gregersen JW.
    Nephrology (Carlton); 2019 Jul; 24(7):703-710. PubMed ID: 30141239
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy.
    Endo M, Fuke Y, Tamano M, Hidaka M, Ohsawa I, Fujita T, Ohi H.
    Nephron Clin Pract; 2004 Jul; 97(4):c147-53. PubMed ID: 15331938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura.
    Dumont C, Mérouani A, Ducruet T, Benoit G, Clermont MJ, Lapeyraque AL, Phan V, Patey N.
    Pediatr Nephrol; 2020 May; 35(5):843-850. PubMed ID: 31932958
    [Abstract] [Full Text] [Related]

  • 10. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy.
    Abe K, Miyazaki M, Koji T, Furusu A, Shioshita K, Tsukasaki S, Ozono Y, Harada T, Sakai H, Kohno S.
    Nephron; 2001 Mar; 87(3):231-9. PubMed ID: 11287758
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S, Yang X, Luo J, Guo H.
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [Abstract] [Full Text] [Related]

  • 16. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR.
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [Abstract] [Full Text] [Related]

  • 17. Complement activation products in the circulation and urine of primary membranous nephropathy.
    Zhang MF, Huang J, Zhang YM, Qu Z, Wang X, Wang F, Meng LQ, Cheng XY, Cui Z, Liu G, Zhao MH.
    BMC Nephrol; 2019 Aug 09; 20(1):313. PubMed ID: 31399080
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.